COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
CinCor Pharma is a Cincinnati-based clinical-stage biopharmaceutical company developing CIN-107 (baxdrostat), an oral selective aldosterone synthase inhibitor, in Phase 2 programs for resistant hypertension, primary aldosteronism, and CKD.
